International Collaborative Network

The International Collaborative Network for N-of-1 Trials and Single-Case Designs (ICN) is a dedicated global network focused on advancing N-of-1 trials and single-case designs. Its core mission is to connect researchers, academics, clinicians, and consumers to enhance both individual and group outcomes. The ICN champions personalized clinical studies as a fundamental component of modern health research and clinical practice, fostering a collaborative environment for innovation and evidence-based approaches.

Operating with a significant presence, the International Collaborative Network comprises 500-1,000 employees and generates $35.2M in revenue. This global entity, headquartered in Australia, facilitates extensive collaboration and discussion among its diverse membership. It provides a robust platform for knowledge exchange through various resources, including active blogs, dedicated forums, and comprehensive training initiatives, all designed to support the network's objectives.

The network's strategic aim is to significantly advance the methodology and application of personalized medicine, with a particular emphasis on supporting individuals with rare diseases. By bringing together experts and stakeholders, the ICN cultivates a dynamic ecosystem for shared learning and development. Explore the collective expertise and dedication of its members; Meet International Collaborative Network's team to understand the driving force behind its impactful work in personalized healthcare.